PRINCETON JUNCTION, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- MISTRAS Group, Inc. (NYSE: MG), a global leader in technology-enabled industrial asset integrity and laboratory testing solutions, issues ...
Net sales for 2026 are projected between $4.2 billion and $4.4 billion, with diluted EPS expected in the range of $20.50 to $23.50. Liguori explained, "At the midpoint, our guidance represents ...
Globus Medical raises 2026 EPS guidance to $4.40-$4.50 with margin gains following record Q4 results
Globus Medical reaffirmed full year 2026 revenue guidance of $3.18 billion to $3.22 billion and increased non-GAAP fully diluted EPS guidance to $4.40 to $4.50 from the previous $4.30 to $4.40. Kline ...
Information reconciling certain forward-looking GAAP measures to non-GAAP measures related to FY 2026 guidance, including organic net sales growth, adjusted operating margin and adjusted free cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results